DK1009380T3 - Fremgangsmåde til fremstilling af farmaceutiske formuleringer - Google Patents
Fremgangsmåde til fremstilling af farmaceutiske formuleringerInfo
- Publication number
- DK1009380T3 DK1009380T3 DK98940460T DK98940460T DK1009380T3 DK 1009380 T3 DK1009380 T3 DK 1009380T3 DK 98940460 T DK98940460 T DK 98940460T DK 98940460 T DK98940460 T DK 98940460T DK 1009380 T3 DK1009380 T3 DK 1009380T3
- Authority
- DK
- Denmark
- Prior art keywords
- formulation
- pharmacologically
- acceptable
- preparation
- administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9718568.0A GB9718568D0 (en) | 1997-09-03 | 1997-09-03 | Compositions |
PCT/GB1998/002637 WO1999011239A1 (en) | 1997-09-03 | 1998-09-02 | Method for preparing pharmaceutical formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1009380T3 true DK1009380T3 (da) | 2003-02-24 |
Family
ID=10818388
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98940460T DK1009380T3 (da) | 1997-09-03 | 1998-09-02 | Fremgangsmåde til fremstilling af farmaceutiske formuleringer |
Country Status (11)
Country | Link |
---|---|
US (1) | US6379692B1 (da) |
EP (1) | EP1009380B1 (da) |
JP (1) | JPH11228386A (da) |
AT (1) | ATE226428T1 (da) |
AU (1) | AU741609B2 (da) |
CA (1) | CA2301325A1 (da) |
DE (1) | DE69808938T2 (da) |
DK (1) | DK1009380T3 (da) |
ES (1) | ES2186207T3 (da) |
GB (2) | GB9718568D0 (da) |
WO (1) | WO1999011239A1 (da) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2396598T3 (es) | 2000-08-25 | 2013-02-22 | Senju Pharmaceutical Co., Ltd. | Preparaciones en forma de suspensiones acuosas |
WO2002026234A1 (fr) * | 2000-09-29 | 2002-04-04 | Wakamoto Pharmaceutical Co., Ltd. | Gouttes ophtalmiques contenant une suspension d'aciclovir |
US20040105889A1 (en) * | 2002-12-03 | 2004-06-03 | Elan Pharma International Limited | Low viscosity liquid dosage forms |
US7101576B2 (en) | 2002-04-12 | 2006-09-05 | Elan Pharma International Limited | Nanoparticulate megestrol formulations |
EP1499361B1 (en) * | 2002-04-19 | 2012-08-08 | Novartis AG | Novel biomaterials, their preparation and use |
JP4512700B2 (ja) * | 2003-06-02 | 2010-07-28 | トーアエイヨー株式会社 | アシクロビル含有水溶液製剤 |
US7947295B2 (en) * | 2003-06-13 | 2011-05-24 | Alcon, Inc. | Ophthalmic compositions containing a synergistic combination of two polymers |
PT2116227E (pt) * | 2003-06-13 | 2013-06-28 | Novartis Ag | Composições oftálmicas que contêm uma combinação sinérgica de dois polímeros |
EP1741425B1 (en) * | 2004-04-05 | 2008-05-28 | Laboratorios Liomont, S.A. de C.V. | Novel antiviral pharmaceutical composition |
AU2005285040A1 (en) * | 2004-09-14 | 2006-03-23 | Molecular Therapeutics, Inc. | D-methionine formulation with improved biopharmaceutical properties |
US20100247666A1 (en) * | 2009-03-24 | 2010-09-30 | Macleod Steven K | Method for Preparing Suspensions of Low-Solubility Materials |
US9775802B2 (en) | 2009-03-24 | 2017-10-03 | Bausch & Lomb Incorporated | Method for preparing suspensions of low-solubility materials |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2080106B (en) | 1980-07-18 | 1984-03-07 | Weelcome Foundation Ltd | Acyclovin preparations |
IE51421B1 (en) | 1980-08-01 | 1986-12-24 | Smith & Nephew Ass | Ophthalmic compositions containing triamterene |
GB2217595B (en) | 1988-04-21 | 1991-11-20 | American Cyanamid Co | Antiinflammatory gel |
GB8919172D0 (en) | 1989-08-23 | 1989-10-04 | Univ Nottingham | Useful composition |
US5252318A (en) | 1990-06-15 | 1993-10-12 | Allergan, Inc. | Reversible gelation compositions and methods of use |
FR2678832B1 (fr) | 1991-07-10 | 1995-03-17 | Europhta Sa Laboratoire | Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation. |
FR2679135B1 (fr) | 1991-07-18 | 1995-05-19 | Europhta Sa Laboratoire | Nouvelles compositions ophtalmiques a adhesivite amelioree et leurs procedes de preparation. |
WO1993017664A1 (en) | 1992-03-02 | 1993-09-16 | Alcon Laboratories, Inc. | Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions |
SE9401108D0 (sv) | 1994-03-31 | 1994-03-31 | Leiras Oy | Ophthalmic composition I |
DE4440337A1 (de) | 1994-11-11 | 1996-05-15 | Dds Drug Delivery Services Ges | Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit |
US5560932A (en) * | 1995-01-10 | 1996-10-01 | Nano Systems L.L.C. | Microprecipitation of nanoparticulate pharmaceutical agents |
JPH08268892A (ja) * | 1995-03-30 | 1996-10-15 | Yuuwa Shoji:Kk | 水溶液製剤及びその製造方法 |
GB2306885B (en) | 1995-11-08 | 1999-07-14 | Reckitt & Colmann Prod Ltd | Supersaturated Pharmaceutical Compositions |
WO1998043643A1 (fr) | 1997-04-01 | 1998-10-08 | Toa Medicine Co., Ltd. | Preparations d'une solution aqueuse d'acyclovir |
-
1997
- 1997-09-03 GB GBGB9718568.0A patent/GB9718568D0/en active Pending
-
1998
- 1998-09-02 CA CA002301325A patent/CA2301325A1/en not_active Abandoned
- 1998-09-02 US US09/145,900 patent/US6379692B1/en not_active Expired - Fee Related
- 1998-09-02 AT AT98940460T patent/ATE226428T1/de not_active IP Right Cessation
- 1998-09-02 AU AU88782/98A patent/AU741609B2/en not_active Ceased
- 1998-09-02 DE DE69808938T patent/DE69808938T2/de not_active Expired - Fee Related
- 1998-09-02 WO PCT/GB1998/002637 patent/WO1999011239A1/en active IP Right Grant
- 1998-09-02 GB GB9818973A patent/GB2328872B/en not_active Expired - Fee Related
- 1998-09-02 ES ES98940460T patent/ES2186207T3/es not_active Expired - Lifetime
- 1998-09-02 EP EP98940460A patent/EP1009380B1/en not_active Expired - Lifetime
- 1998-09-02 DK DK98940460T patent/DK1009380T3/da active
- 1998-09-03 JP JP10265712A patent/JPH11228386A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU8878298A (en) | 1999-03-22 |
GB9718568D0 (en) | 1997-11-05 |
JPH11228386A (ja) | 1999-08-24 |
EP1009380A1 (en) | 2000-06-21 |
AU741609B2 (en) | 2001-12-06 |
CA2301325A1 (en) | 1999-03-11 |
DE69808938D1 (de) | 2002-11-28 |
GB2328872B (en) | 2002-04-03 |
GB9818973D0 (en) | 1998-10-21 |
EP1009380B1 (en) | 2002-10-23 |
US6379692B1 (en) | 2002-04-30 |
ATE226428T1 (de) | 2002-11-15 |
GB2328872A (en) | 1999-03-10 |
ES2186207T3 (es) | 2003-05-01 |
WO1999011239A1 (en) | 1999-03-11 |
DE69808938T2 (de) | 2003-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS4146A (is) | Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara | |
BR0008590A (pt) | Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto | |
ES2110377T1 (es) | Formulacion galenica de fenofibrato y aplicacion de la misma. | |
FI950319A0 (fi) | Säädellyn vapautumisnopeuden omaava morfiinivalmiste | |
DE69919713D1 (de) | Pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung von phenytoin natrium | |
YU66600A (sh) | Farmaceutski preparati koji mogu da budu gelirani | |
BR0011772A (pt) | Conjugado de droga-oligÈmero, composição farmacêutica, método de solubilização de uma droga em uma microemulsão, e, métodos para fornecer um conjugado de droga ativa - hidrófilo e um conjugado de droga ativa - peg a um sìtio de um indivìduo | |
HUP0004924A2 (hu) | Ciklodextrineket tartalmazó gyógyászati készítmények | |
ATE204467T1 (de) | Orale darreichungsform | |
ATE544447T1 (de) | Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung | |
EP0221041A3 (en) | Benzimidazole derivatives, process for their preparation and their pharmaceutical use | |
ATE198152T1 (de) | Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe | |
DK1009380T3 (da) | Fremgangsmåde til fremstilling af farmaceutiske formuleringer | |
HUP0002490A2 (hu) | Csersav-polimer kompozíciók gyógyászati anyagok szabályozott leadására, különösen a szájüregben | |
ATE311373T1 (de) | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen | |
IL92797A0 (en) | Therapeutical active substituted benzimidazole and process for its preparation | |
DE69922017D1 (de) | Arzneimittel und verfahren zur behandlung von intrazellulären infektionen | |
BG60101B2 (bg) | Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол | |
ATE126052T1 (de) | System zur gesteuerten freisetzung von wirkstoffen sowie verfahren zu dessen herstellung. | |
DK1146864T3 (da) | pH-uafhængig farmaceutisk formulering med forlænget frisætning | |
DK0693926T3 (da) | Ny farmaceutisk sammensætning til fremstilling af et stabilt pulver indeholdende en kombination af acetylsalicylsyre og metoclopramid som aktiv bestanddel. | |
GEP20022751B (en) | Aqueous Pharmaceutical Composition Comprising an Active Ingredient Which Is Highly Insoluble in Water | |
ATE324103T1 (de) | Arzneizubereitung mit kontrollierter freisetzung enthaltend tramadol hydrochlorid | |
EP0815851A3 (en) | Method of reducing irritativeness of surface active agents and aqueous compositions with reduced irritativeness | |
KR910015297A (ko) | 오메프라졸 경구용 약제와 그 제조방법 |